Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide CRISPR/Cas9 screens reveal shared and cell-specific mechanisms of resistance to SHP2 inhibition. | J Exp Med | 2023 | 36820830 | PubTator, text mining | PubMed |
| Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. | J Pharm Anal | 2023 | 36820078 | PubTator, text mining | PubMed |
| LSM1-mediated Major Satellite RNA decay is required for nonequilibrium histone H3.3 incorporation into parental pronuclei. | Nat Commun | 2023 | 36810573 | PubTator, text mining | PubMed |
| Comprehensive chromatin proteomics resolves functional phases of pluripotency and identifies changes in regulatory components. | Nucleic Acids Res | 2023 | 36806742 | PubTator, text mining | PubMed |
| Modulating epigenetic modifications for cancer therapy (Review). | Oncol Rep | 2023 | 36799181 | PubTator, text mining | PubMed |
| Transfer RNA-derived small RNAs in tumor microenvironment. | Mol Cancer | 2023 | 36797764 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators to overcome drug resistance in cancers. | Signal Transduct Target Ther | 2023 | 36797239 | PubTator, text mining | PubMed |
| [Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence and Progression]. | Zhongguo Fei Ai Za Zhi | 2023 | 36792079 | PubTator, text mining | PubMed |
| Emerging roles of tRNA-derived fragments in cancer. | Mol Cancer | 2023 | 36782290 | PubTator, text mining | PubMed |
| Transposable Elements Co-Option in Genome Evolution and Gene Regulation. | Int J Mol Sci | 2023 | 36768929 | PubTator, text mining | PubMed |
| Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor-A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer. | Int J Mol Sci | 2023 | 36768182 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells. | Transl Lung Cancer Res | 2023 | 36762066 | PubTator, text mining | PubMed |
| tRNA derived fragments:A novel player in gene regulation and applications in cancer. | Front Oncol | 2023 | 36761955 | PubTator, text mining | PubMed |
| An old friend with a new face: tRNA-derived small RNAs with big regulatory potential in cancer biology. | Br J Cancer | 2023 | 36759729 | PubTator, text mining | PubMed |
| Multifaceted functions of RNA-binding protein vigilin in gene silencing, genome stability, and autism-related disorders. | J Biol Chem | 2023 | 36758804 | PubTator, text mining | PubMed |
| Could senescence phenotypes strike the balance to promote tumor dormancy? | Cancer Metastasis Rev | 2023 | 36735097 | PubTator, text mining | PubMed |
| Chromobox proteins in cancer: Multifaceted functions and strategies for modulation (Review). | Int J Oncol | 2023 | 36734270 | PubTator, text mining | PubMed |
| The epigenetic players and the chromatin marks involved in the articular cartilage during osteoarthritis. | Front Physiol | 2023 | 36733912 | PubTator, text mining | PubMed |
| The dynamics of chromatin states mediated by epigenetic modifications during somatic cell reprogramming. | Front Cell Dev Biol | 2023 | 36727112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=19